Fulltext:
88215.pdf
Embargo:
until further notice
Size:
671.6Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2010Author(s)
Source
Cell, 140, 6, (2010), pp. 935-50ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Internal Medicine
Journal title
Cell
Volume
vol. 140
Issue
iss. 6
Page start
p. 935
Page end
p. 50
Subject
N4i 1: Pathogenesis and modulation of inflammationAbstract
Inflammation involving the innate and adaptive immune systems is a normal response to infection. However, when allowed to continue unchecked, inflammation may result in autoimmune or autoinflammatory disorders, neurodegenerative disease, or cancer. A variety of safe and effective anti-inflammatory agents are available, including aspirin and other nonsteroidal anti-inflammatories, with many more drugs under development. In particular, the new era of anti-inflammatory agents includes "biologicals" such as anticytokine therapies and small molecules that block the activity of kinases. Other anti-inflammatories currently in use or under development include statins, histone deacetylase inhibitors, PPAR agonists, and small RNAs. This Review discusses the current status of anti-inflammatory drug research and the development of new anti-inflammatory therapeutics.
This item appears in the following Collection(s)
- Academic publications [243179]
- Electronic publications [129877]
- Faculty of Medical Sciences [92416]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.